| Symbol | Company | Weighting |
|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 2.93% |
| GH | GUARDANT HEALTH INC | 2.81% |
| SRPT | SAREPTA THERAPEUTICS INC | 2.79% |
| BEAM | BEAM THERAPEUTICS INC | 2.52% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.21% |
| DNLI | DENALI THERAPEUTICS INC. | 2.20% |
| NTRA | NATERA INC | 2.15% |
| RGEN | REPLIGEN CORP | 2.14% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.09% |
| CYTK | CYTOKINETICS INC | 2.08% |
| ADUS | ADDUS HOMECARE CORPORATION | 2.04% |
| RMD | RESMED INC | 2.01% |
| HQY | HEALTHEQUITY INC | 1.99% |
| CERE | CEREVEL THERAPEUTICS HLD | 1.96% |
| MOH | MOLINA HEALTHCARE INC | 1.95% |
| UTHR | UNITED THERAPEUTICS CORPS | 1.92% |
| ARGX | ARGENX SE ADR | 1.89% |
| ACHC | ACADIA HEALTHCARE CO INC | 1.89% |
| LNTH | LANTHEUS HOLDINGS INC | 1.89% |
| UNH | UNITEDHEALTH GROUP INC | 1.88% |
| MCK | MCKESSON CORP | 1.82% |
| HUM | HUMANA INC | 1.81% |
| CI | CIGNA CORP NEW | 1.80% |
| REGN | REGENERON PHARMACEUTICALS | 1.77% |
| MASI | MASIMO CORP | 1.77% |
| DXCM | DEXCOM INC | 1.74% |
| NVO | NOVO NORDISK A/S | 1.69% |
| BSX | BOSTON SCIENTIFIC | 1.68% |
| RXDX | PROMETHEUS BIOSCIENCES | 1.65% |
| BMY | BRISTOL MYERS SQUIBB CO | 1.64% |
| ZTS | ZOETIS INC | 1.61% |
| ICLR | ICON PLC | 1.59% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.59% |
| IQV | IQVIA HOLDINGS INC | 1.57% |
| BDX | BECTON DICKINSON & CO | 1.57% |
| ABC | AMERISOURCEBERGEN CORP | 1.55% |
| ABBV | ABBVIE INC | 1.54% |
| SYK | STRYKER CORP | 1.54% |
| ABT | ABBOTT LABORATORIES | 1.53% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.53% |
| MDRX | ALLSCRIPTS HEALTHCARE SOLUTIONS INC | 1.52% |
| AZN | ASTRAZENECA PLC-ADR | 1.51% |
| HCA | HCA HOLDINGS INC | 1.50% |
| NUVA | NUVASIVE | 1.42% |
| ITCI | INTRA-CELLULAR THERAPIES USD | 1.41% |
| LIVN | LIVANOVA PLC | 1.36% |
| ILMN | ILLUMINA INC | 1.34% |
| RCKT | ROCKET PHARMACEUTICALS INC USD | 1.34% |
| OMI | OWENS & MINOR INC NEW | 1.21% |
| QURE | UNIQURE NV | 1.20% |
| AXSM | AXSOME THERAPEUTICS INC. | 1.20% |
| SYNH | SYNEOS HEALTH INC | 1.19% |
| HZNP | HORIZON THERAPEUTICS PLC | 1.19% |
| AVTR | AVANTOR, INC. | 1.12% |
| XENE | XENON PHARMACEUTICALS | 1.05% |
| RNA | AVIDITY BIOSCIENCES INC | 0.99% |
| XNCR | XENCOR INC. | 0.94% |
| TVTX | TRAVERE THERAPEUTICS INC | 0.87% |
| AMPH | AMPHASTAR PHARMACEUTICALS INC | 0.71% |
| EYPT | EYEPOINT PHARMACEUTICALS | 0.68% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2022 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.